Aug. 4, 2016
PET imaging of adult neurogenesis may contribute to better diagnosis of depression and evaluation of drug therapy effectiveness
Scientists from the RIKEN Center for Life Science Technology (CLST) in Japan have used a new non-invasive PET scanning technique to obtain images of neuron proliferation in the subventricular zone and subgranular zone of the hippocampal dentate gyrus. Neurogenesis in the hippocampal dentate gyrus is known to be particularly affected by depression.
These two areas are known to be neurogenic regions, where neural stem cells give rise to new neurons throughout our lives. Hippocampal neurogenesis is known to be associated with depression and the effect of antidepressive medication, but it is also involved in learning and memory, so scientists are keen to find techniques that can monitor cell proliferation in the region. However, the process of neurogenesis is very hard to monitor non-invasively. It is possible using magnetic resonance imaging, but with MRI the tracers do not move into the brain effectively and must be injected directly into the brain fluid, making is invasive and difficult to perform.
Positron emission tomography (PET) is another method that has been used. Previously, attempts have been made to use a molecule called [18F]FLT as a marker for cell proliferation in the brain in PET, but unfortunately the difference in signal strength between regions with and without cell growth was small. “We were not exactly sure why this was happening,” says Tamura, “but surmised that it is because the body actively pumps the molecule out of the brain through the blood-brain barrier, using active transport mechanisms. This means that it is difficult for [18F]FLT to accumulate in the brain in sufficient concentrations to allow effective imaging.”
To test whether this was the case, they tried injecting rats with a drug called probenecid, which is known to inhibit the active transport of molecules like [18F]FLT outside of the brain. They were happy to see that the strategy worked. They found clear signals of neurogenesis in the two areas of the adult brain, and these signals were significantly decreased in the hippocampal dentate gyrus of rats that had been treated with corticosterone to trigger depression. When the rats were treated with an anti-depressive selective serotonin reuptake inhibitor, the amount of cell proliferation was shown to increase, demonstrating that the drugs were countering the loss of neurogenesis caused by the corticosterone.
According to Yosky Kataoka, who led the research team, “This is a very interesting finding, because it has been a longtime dream to find a non-invasive test that can give objective evidence of depression and simultaneously show whether drugs are working in a given patient. We have shown that it is possible, at least in experimental animals, to use PET to show the presence of depression and the effectiveness of drugs. Since it is known that these same brain regions are involved in depression in the human brain, we would like to try this technique in the clinic and see whether it turns out to be effective in humans as well.”
The research was published in theJournal of Neuroscience.
- Yasuhisa Tamura et al., Noninvasive Evaluation of Cellular Proliferative Activity in Brain Neurogenic Regions in Rats under Depression and Treatment by Enhanced [18F]FLT-PET Imaging, The Journal of Neuroscience, DOI:10.1523/JNEUROSCI.0220-16.2016
Cellular Function Imaging Team
Imaging Function Group
Division of Bio-Function Dynamics Imaging
RIKEN Center for Life Science Technologies
RIKEN International Affairs Division
Tel: +81-(0)48-462-1225 / Fax: +81-(0)48-463-3687
PET images show increased accumulation of the tracer [18F]FLT in rats treated with probenecid (right) in the subventricular zone (a) and subgranular zone (b) of the hippocampal dentate gyrus.
[18F]FLT images clearly show decreased neurogenesis in rats treated with corticosterone (second from left), which is restored in rats treated with corticosterone and fluoxetine, an SSRI anti-depressant.